Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Chronic Inflammation: Introduction

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Myasthenia Gravis ll: Pathophysiology

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of non-communicable diseases on maternal and perinatal outcomes in a low resource setting.

Maternal health, neonatology and perinatology·2025

Same author

Induction of labour using cervical double-balloon (Cook catheter) in outpatient versus inpatient setting (COOK study): a multicentre, open-label, randomised controlled trial.

European journal of obstetrics, gynecology, and reproductive biology·2025

Same author

EUSOMA and NCCN should include clinical staging after neoadjuvant therapy as a quality indicator for treatment guidance.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025

Same author

Interpregnancy and pregnancy lifestyle intervention (INTER-ACT): a randomized controlled trial.

American journal of obstetrics and gynecology·2025

Same author

Associations Between Non-communicable Diseases and Obstetric Complications: A Retrospective Records Review at a Tertiary Referral Hospital in Uganda.

Cureus·2024

Same author

First diagnosis of severe coarctation of the aorta necessitating percutaneous intervention during pregnancy: a case report.

European heart journal. Case reports·2024

Search research articles

Related Experiment Video

Updated: May 16, 2026

Isolation and Culture of Primary Human Mammary Epithelial Cells

Isolation and Culture of Primary Human Mammary Epithelial Cells

Published on: May 3, 2024

Idiopathic ganulomatous mastitis.

Christelle Van Casteren¹, Yves Jacquemyn, Ellen Himpe

¹Department of Obstetrics, UZA, Edegem, Antwerp, Belgium.

BMJ Case Reports

|November 29, 2012

Summary

Idiopathic granulomatous mastitis (IGM) is a rare chronic breast condition. Steroid treatment shows promise for managing this benign disease, offering an alternative to surgery.

Area of Science:

Breast pathology
Dermatology
Oncology

Background:

Idiopathic granulomatous mastitis (IGM) is a rare, chronic, benign breast disease.
Histological features include inflammatory reactions and non-caseating granulomas.
IGM is frequently misdiagnosed as breast cancer or complicated mastitis.

Observation:

Surgical interventions for IGM can lead to breast mutilation.
There is no established consensus on the optimal treatment strategy for IGM.
Low-dose oral and topical steroids have demonstrated effectiveness in managing IGM.

Findings:

Non-caseating granulomas are a hallmark histological finding in IGM.
Steroid therapy offers a viable, less invasive treatment option.

More Related Videos

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Published on: September 4, 2012

Related Experiment Videos

Last Updated: May 16, 2026

Isolation and Culture of Primary Human Mammary Epithelial Cells

Isolation and Culture of Primary Human Mammary Epithelial Cells

Published on: May 3, 2024

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Intraductal Injection of LPS as a Mouse Model of Mastitis: Signaling Visualized via an NF-κB Reporter Transgenic

Published on: September 4, 2012

Early diagnosis and appropriate management are crucial to avoid unnecessary surgeries.

Implications:

Steroid treatment may reduce the need for breast-disfiguring surgeries.
Further research into standardized IGM treatment protocols is warranted.
Improved diagnostic criteria can prevent misdiagnosis and guide effective therapy.